ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:EthicsLegal UpdatesLegislation & AdvocacyResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

American College of Rheumatology Backs Bill to Prevent Cuts to Infusion Reimbursement

Richard Quinn  |  August 21, 2013

The ACR has endorsed a proposed law that would exempt physician-administered drugs from future Medicare sequestration. (posted Aug. 21, 2013)

Why I Advocate for Arthritis: A Patient’s Perspective

Rev. Anthony J. Hillelson  |  August 1, 2013

Reverend Anthony J. Hillelson, who has rheumatoid arthritis, on why he lobbies Congress to support rheumatic disease research funding

Healthcare Providers Must Get Compliant with HIPAA Privacy Practices

Steven M. Harris, Esq.  |  August 1, 2013

Failure to have an updated Notice of Privacy Practices by September 23, 2013 could result in fines and penalties

New Methodology to Improve Cartilage Repair

Lara C. Pullen, PhD  |  July 31, 2013

A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells.  (posted July 31, 2013)

B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis

Lara C. Pullen, PhD  |  July 31, 2013

Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)

Congress Considers More Regulation for Manufacturers of Compounding Drugs

Richard Quinn  |  July 22, 2013

New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)

President’s Perspective: Will the Physician Payment Sunshine Act Shed Light on Conflicts of Interest?

Audrey B. Uknis, MD  |  July 1, 2013

What rheumatologists should know about complying with the PPSA when it goes into effect on August 1

How Rheumatologists Can Connect with Congress during August Recess

Staff  |  July 1, 2013

Tips for scheduling an in-person meeting and issues to discuss with lawmakers at their district offices

Rheumatology Drug Research Should Focus on Particular Groups of Patients

Deborah Levenson  |  July 1, 2013

An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment

California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis

Stephanie Cajigal  |  July 1, 2013

Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says

  • « Previous Page
  • 1
  • …
  • 189
  • 190
  • 191
  • 192
  • 193
  • …
  • 249
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences